Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Neural Regeneration Research
|
June 5, 2018
Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
Jordi Bruna, Roser Velasco
Toxics
|
October 24, 2017
Taxane-Induced Peripheral Neurotoxicity
Roser Velasco, Jordi Bruna
Expert Review of Clinical Pharmacology
|
May 10, 2013
Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment
Jordi Bruna, Júlia Miró, Roser Velasco
JAMA Neurology
|
May 12, 2020
Paraneoplastic Encephalomyelitis With Glutamic Acid Decarboxylase Antibodies Presenting as Longitudinal Pyramidal Tract Hyperintensity
Oriol Miralles, Núria Caballol, Roser Velasco
Current Treatment Options in Neurology
|
June 28, 2012
Leptomeningeal metastases
Jordi Bruna, Marta Simó, Roser Velasco
Cancers
|
December 10, 2021
Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy
Roser Velasco, Eva Domingo-Domenech, Anna Sureda
Journal of the Neurological Sciences
|
May 6, 2025
Methotrexate-induced neurotoxicity in oncology: Current issues for a classic drug
Sarah Besora, Ytel Garcilazo-Reyes, Roser Velasco
Neuro-Oncology Practice
|
March 5, 2021
Late effects of cancer treatment: consequences for long-term brain cancer survivors
Montse Alemany, Roser Velasco, Marta Simó, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 15, 2017
Hypoglossal myokymia presenting as paroxysmal dysarthria following head and neck radiotherapy
Tiago Geraldes, Montserrat Alemany, Alicia Lozano, et al.
Journal of Personalized Medicine
|
August 6, 2021
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
Roser Velasco, Montserrat Alemany, Macarena Villagrán, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Neural Regeneration Research
|
June 5, 2018
Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
Jordi Bruna, Roser Velasco
Toxics
|
October 24, 2017
Taxane-Induced Peripheral Neurotoxicity
Roser Velasco, Jordi Bruna
Expert Review of Clinical Pharmacology
|
May 10, 2013
Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment
Jordi Bruna, Júlia Miró, Roser Velasco
JAMA Neurology
|
May 12, 2020
Paraneoplastic Encephalomyelitis With Glutamic Acid Decarboxylase Antibodies Presenting as Longitudinal Pyramidal Tract Hyperintensity
Oriol Miralles, Núria Caballol, Roser Velasco
Current Treatment Options in Neurology
|
June 28, 2012
Leptomeningeal metastases
Jordi Bruna, Marta Simó, Roser Velasco
Cancers
|
December 10, 2021
Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy
Roser Velasco, Eva Domingo-Domenech, Anna Sureda
Journal of the Neurological Sciences
|
May 6, 2025
Methotrexate-induced neurotoxicity in oncology: Current issues for a classic drug
Sarah Besora, Ytel Garcilazo-Reyes, Roser Velasco
Neuro-Oncology Practice
|
March 5, 2021
Late effects of cancer treatment: consequences for long-term brain cancer survivors
Montse Alemany, Roser Velasco, Marta Simó, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 15, 2017
Hypoglossal myokymia presenting as paroxysmal dysarthria following head and neck radiotherapy
Tiago Geraldes, Montserrat Alemany, Alicia Lozano, et al.
Journal of Personalized Medicine
|
August 6, 2021
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
Roser Velasco, Montserrat Alemany, Macarena Villagrán, et al.
Page
of 6